Showing 3081-3090 of 21431 results for "".
- Harnessing Helminths: Extracellular Vesicles as a Novel Therapeutic Pathway in Inflammatory Diseaseshttps://reachmd.com/news/harnessing-helminths-extracellular-vesicles-as-a-novel-therapeutic-pathway-in-inflammatory-diseases/2471113/Recent studies have unveiled the potential of helminth extracellular vesicles in modulating immune responses, potentially revolutionizing treatments for inflammatory diseases. Breakthrough in Helminth Therapy for Inflammatory Bowel Disease
- Unveiling the Role of Granzyme K in Chronic Inflammatory Diseaseshttps://reachmd.com/news/unveiling-the-role-of-granzyme-k-in-chronic-inflammatory-diseases/2471106/Quick Summary Granzyme K, a protein largely expressed by CD8+ T cells, has been identified as a key driver in activating the complement system, leading to inflammation and tissue damage in autoimmune diseases. This discovery offers new therapeutic possibilities for
- Advancements in Informational Support for Women with Endometriosishttps://reachmd.com/news/advancements-in-informational-support-for-women-with-endometriosis/2471089/Quick Summary A scoping review conducted by Deniz Senyel and colleagues maps current literature on the informational needs and seeking behaviors of women with endometriosis. The review found that although there are various informational resources available, they are
- Intermittent Fasting as a Nonpharmacological Aid for Rheumatoid Arthritis in Postmenopausal Womenhttps://reachmd.com/news/intermittent-fasting-as-a-nonpharmacological-aid-for-rheumatoid-arthritis-in-postmenopausal-women/2471068/Quick Summary The study published in Scientific Reports examined the impact of intermittent fasting on postmenopausal women with rheumatoid arthritis. The findings revealed significant improvements in antioxidant and inflammatory markers, suggesting that intermitten
- Potential Shift in Lipodystrophy Treatment: Weekly Tirzepatide Injectionhttps://reachmd.com/news/potential-shift-in-lipodystrophy-treatment-weekly-tirzepatide-injection/2471084/What's New A groundbreaking study by Rutgers Health suggests a weekly tirzepatide injection could significantly improve treatment for congenital generalized lipodystrophy, potentially replacing painful daily hormone shots. Significance This developme
- The Influence of Sleep Position on Heart and Brain Health: An Evidence-Based Discussionhttps://reachmd.com/news/the-influence-of-sleep-position-on-heart-and-brain-health-an-evidence-based-discussion/2471081/What's New New research highlights the possible effects of sleep position on heart and brain health, especially concerning sleep apnea. Significance Understanding the implications of sleep position can aid healthcare professionals in offering better
- Advancements in Tau Imaging for Alzheimer's Disease: A Comparative Analysishttps://reachmd.com/news/advancements-in-tau-imaging-for-alzheimers-disease-a-comparative-analysis/2471074/What's New Recent developments in tau imaging reveal that next-generation radiotracers offer superior detection capabilities for Alzheimer's disease. This finding could significantly impact the early diagnosis and treatment strategies for this prevalent condition.</
- Addressing the Gaps in Pain Management for Preterm Infants: Insights from a Swedish Studyhttps://reachmd.com/news/addressing-the-gaps-in-pain-management-for-preterm-infants-insights-from-a-swedish-study/2471079/What's New A nationwide Swedish study highlights the inadequacies in pain management for preterm infants, revealing a high prevalence of painful procedures but frequent underdiagnosis and undertreatment. Significance The findings are crucial for heal
- COVID-19's Hidden Impact: The Virus's Damage to Cardiovascular Healthhttps://reachmd.com/news/covid-19s-hidden-impact-the-viruss-damage-to-cardiovascular-health/2471082/What's New New research reveals the mechanisms by which SARS-CoV-2, the virus responsible for COVID-19, harms blood vessels and the heart, increasing cardiovascular risk. Significance Understanding the cardiovascular implications of COVID-19 is cruci
- Study: Newer Biologics Do Not Increase MACE/VTE Risk in PsO/PsAhttps://reachmd.com/news/Study-Newer-Biologics-Do-Not-Increase-MACE-VTE-Risk-PsO-PsA/2471065/A new emulated target trial analysis found no significant risk differences in major adverse cardiovascular events (MACE) or venous thromboembolic events (VTE) in patients with psoriasis or psoriatic arthritis treated with IL-17, IL-12/23, or IL-23 inhibitors vs those treated with TNF inhibitors.<